Bharat Biotech
Bharat Biotech is a Private Indian company incorporated in 1996 and based in Telangana, India. Bharat Biotech operates in Pharmaceuticals & Chemicals (NIC 24230) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Bharat Biotech - Manufacturer of vaccines and bio-therapeutic products. Raised a total funding of $13.7M over 6 rounds from 27 investors.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Bharat Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +14d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Bharat Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 787674757 | ICICI Bank Ltd(Bank) | ₹17.85 Cr | 27 Jan 2020 | Satisfied |
| 678758369 | State Bank of India(Bank) | ₹12.14 Cr | 19 Sep 2019 | Open |
| 614661846 | State Bank of India(Bank) | ₹19.34 Cr | 27 Jan 2020 | Open |
| 150196162 | HDFC Bank Ltd(Bank) | ₹11.29 Cr | 12 Mar 2023 | Open |
Charge IDs, lenders & amounts for Bharat Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹16.13 Cr | ₹1.96 Cr | ₹15.78 Cr | ₹24.23 Cr | 98 |
| FY2023-24 | ₹13.60 Cr | ₹1.51 Cr | ₹12.64 Cr | ₹22.93 Cr | 271 |
| FY2022-23 | ₹12.52 Cr | ₹1.44 Cr | ₹7.03 Cr | ₹15.88 Cr | 315 |
| FY2021-22 | ₹11.84 Cr | ₹1.42 Cr | ₹10.69 Cr | ₹19.07 Cr | 183 |
Audited financials & ratios for Bharat Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹16.13 Cr | ₹13.60 Cr | ₹12.52 Cr | ₹11.84 Cr |
| Other income | ₹13.42 L | ₹35.91 L | ₹7.85 L | ₹19.41 L |
| Total income | ₹16.26 Cr | ₹13.96 Cr | ₹12.59 Cr | ₹12.04 Cr |
| Total expenses | ₹13.75 Cr | ₹12.03 Cr | ₹10.75 Cr | ₹10.22 Cr |
| Profit before tax | ₹2.55 Cr | ₹1.96 Cr | ₹1.88 Cr | ₹1.85 Cr |
| Profit / (Loss) after tax | ₹1.96 Cr | ₹1.51 Cr | ₹1.44 Cr | ₹1.42 Cr |
| Balance sheet | ||||
| Equity / Net worth | ₹15.78 Cr | ₹12.64 Cr | ₹7.03 Cr | ₹10.69 Cr |
| Borrowings | ₹2.40 Cr | ₹3.61 Cr | ₹4.40 Cr | ₹2.78 Cr |
| Current liabilities | ₹4.69 Cr | ₹3.82 Cr | ₹4.14 Cr | ₹2.84 Cr |
| Total liabilities | ₹8.45 Cr | ₹10.29 Cr | ₹8.85 Cr | ₹8.38 Cr |
| Current assets | ₹14.08 Cr | ₹9.42 Cr | ₹6.45 Cr | ₹9.39 Cr |
| Cash & equivalents | ₹4.57 Cr | ₹2.22 Cr | ₹2.41 Cr | ₹3.66 Cr |
| Total assets | ₹24.23 Cr | ₹22.93 Cr | ₹15.88 Cr | ₹19.07 Cr |
| Employees | 98 | 271 | 315 | 183 |
Audited financials & ratios for Bharat Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹16.13 Cr | +18.8% | +10.8% | +9.5% |
| Profit after Tax | ₹1.96 Cr | +12.8% | +20.5% | +14.9% |
| Net Worth | ₹15.78 Cr | -11.1% | +27.8% | +7.0% |
| Employees | 98 | +22.7% | +7.3% | +0.7% |
Audited financials & ratios for Bharat Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹16.13 Cr | ₹1.96 Cr | +12.17% | +22.47% | +12.44% | +8.11% | 0.15 | ₹16.46 L |
| FY2023-24 | ₹13.60 Cr | ₹1.51 Cr | +11.10% | +26.37% | +11.95% | +6.59% | 0.29 | ₹5.02 L |
| FY2022-23 | ₹12.52 Cr | ₹1.44 Cr | +11.53% | -5.22% | +20.54% | +9.09% | 0.63 | ₹3.97 L |
| FY2021-22 | ₹11.84 Cr | ₹1.42 Cr | +12.00% | +23.39% | +13.30% | +7.45% | 0.26 | ₹6.47 L |
Audited financials & ratios for Bharat Biotech.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 27,26,177 | 55.11% |
| Institutional Investors | 2 | 9,04,570 | 18.29% |
| Public & Others | 28 | 13,15,933 | 26.60% |
Promoter, institutional & public holding for Bharat Biotech.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
49 peersEvents & timeline
1External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.